In 2017, Jadidi-Niaragh et al. evaluated the efficacy of CD73-specific siRNA-loaded chitosan-lactate nanoparticles in combination with tumor lysate-pulsed DCs vaccine for the treatment of 4T1 breast cancer-bearing mice. Here, NT5E is linked to neoplasm.